Patients benefit when physicians and researchers collaborate with the private sector to advance the development of effective new drugs and medical devices. However, there is widespread concern that extensive financial relationships between providers and industry, particularly payments associated with product promotion, may unduly influence the care that patients receive.
Such conflicts of interest threaten the integrity of scientific investigations, the objectivity of professional education, the quality of patient care, and the public’s trust in medicine.Institute of Medicine
Direct marketing by the pharmaceutical industry to medical professionals is estimated at $20 to $57 billion each year. A national survey published in the Archives of Internal Medicine found that 84 percent of doctors have some type of financial relationship with the pharmaceutical industry.
Pew’s work in this area seeks to ensure transparency in physician-industry relationships and promotes policies to reduce or manage conflicts of interest that could affect patient care. Our efforts have supported the creation of new policies at medical schools, professional medical associations, and have successfully supported state and federal disclosure laws.
Recommendations for Best Practices
Our WorkView All
On September 2, Pew submitted comments to the Centers for Medicare & Medicaid Services (CMS) in response to proposed regulations which would change reporting under the Physician Payment Sunshine Act. Pew supports the elimination of the continuing medical education exclusion, and urges CMS to implement the Sunshine Act in the best interest of consumers. Read More
The pharmacuetical and medical device industries promote their products vigorously to patients and physicians. Read More
The federal government's Centers for Medicare & Medicaid Services yesterday began allowing pharmaceutical and medical device companies to register online for the new “Open Payments” website, authorized under the Physician Payments Sunshine Act to make more transparent the disclosure of financial interactions among physicians. The announcement is a critical first step to bring... Read More